View in EDS

Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.

Saved in:
Bibliographic Details
Title: Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.
Authors: Hoppes R; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Oostvogels R; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands Department of Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;, Luimstra JJ; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Wals K; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Toebes M; Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Bies L; Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Ekkebus R; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Rijal P; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Celie PH; Division of Biochemistry, The Netherlands Cancer Institute Protein Facility, 1066 CX Amsterdam, the Netherlands; and., Huang JH; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands., Emmelot ME; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands., Spaapen RM; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Lokhorst H; Department of Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;, Schumacher TN; Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Mutis T; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands., Rodenko B; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, United Kingdom b.rodenko@nki.nl h.ovaa@nki.nl., Ovaa H; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;
Source: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2014 Nov 15; Vol. 193 (10), pp. 4803-13. Date of Electronic Publication: 2014 Oct 13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 25311806
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hoppes+R%22">Hoppes R</searchLink>; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;<br /><searchLink fieldCode="AU" term="%22Oostvogels+R%22">Oostvogels R</searchLink>; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands Department of Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;<br /><searchLink fieldCode="AU" term="%22Luimstra+JJ%22">Luimstra JJ</searchLink>; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;<br /><searchLink fieldCode="AU" term="%22Wals+K%22">Wals K</searchLink>; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;<br /><searchLink fieldCode="AU" term="%22Toebes+M%22">Toebes M</searchLink>; Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;<br /><searchLink fieldCode="AU" term="%22Bies+L%22">Bies L</searchLink>; Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;<br /><searchLink fieldCode="AU" term="%22Ekkebus+R%22">Ekkebus R</searchLink>; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;<br /><searchLink fieldCode="AU" term="%22Rijal+P%22">Rijal P</searchLink>; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;<br /><searchLink fieldCode="AU" term="%22Celie+PH%22">Celie PH</searchLink>; Division of Biochemistry, The Netherlands Cancer Institute Protein Facility, 1066 CX Amsterdam, the Netherlands; and.<br /><searchLink fieldCode="AU" term="%22Huang+JH%22">Huang JH</searchLink>; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Emmelot+ME%22">Emmelot ME</searchLink>; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Spaapen+RM%22">Spaapen RM</searchLink>; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;<br /><searchLink fieldCode="AU" term="%22Lokhorst+H%22">Lokhorst H</searchLink>; Department of Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;<br /><searchLink fieldCode="AU" term="%22Schumacher+TN%22">Schumacher TN</searchLink>; Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;<br /><searchLink fieldCode="AU" term="%22Mutis+T%22">Mutis T</searchLink>; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Rodenko+B%22">Rodenko B</searchLink>; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, United Kingdom b.rodenko@nki.nl h.ovaa@nki.nl.<br /><searchLink fieldCode="AU" term="%22Ovaa+H%22">Ovaa H</searchLink>; Division of Cell Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985117R%22">Journal of immunology (Baltimore, Md. : 1950)</searchLink> [J Immunol] 2014 Nov 15; Vol. 193 (10), pp. 4803-13. <i>Date of Electronic Publication: </i>2014 Oct 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985117R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1550-6606 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221767%22">00221767 </searchLink><i>NLM ISO Abbreviation: </i>J Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25311806
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.4049/jimmunol.1400800
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4803
    Titles:
      – TitleFull: Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hoppes R
      – PersonEntity:
          Name:
            NameFull: Oostvogels R
      – PersonEntity:
          Name:
            NameFull: Luimstra JJ
      – PersonEntity:
          Name:
            NameFull: Wals K
      – PersonEntity:
          Name:
            NameFull: Toebes M
      – PersonEntity:
          Name:
            NameFull: Bies L
      – PersonEntity:
          Name:
            NameFull: Ekkebus R
      – PersonEntity:
          Name:
            NameFull: Rijal P
      – PersonEntity:
          Name:
            NameFull: Celie PH
      – PersonEntity:
          Name:
            NameFull: Huang JH
      – PersonEntity:
          Name:
            NameFull: Emmelot ME
      – PersonEntity:
          Name:
            NameFull: Spaapen RM
      – PersonEntity:
          Name:
            NameFull: Lokhorst H
      – PersonEntity:
          Name:
            NameFull: Schumacher TN
      – PersonEntity:
          Name:
            NameFull: Mutis T
      – PersonEntity:
          Name:
            NameFull: Rodenko B
      – PersonEntity:
          Name:
            NameFull: Ovaa H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 11
              Text: 2014 Nov 15
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1550-6606
          Numbering:
            – Type: volume
              Value: 193
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Journal of immunology (Baltimore, Md. : 1950)
              Type: main
ResultId 1